<DOC>
	<DOC>NCT00751400</DOC>
	<brief_summary>The purpose of this Study is to assess how subjects will use the investigational product in an uncontrolled, naturalistic environment.</brief_summary>
	<brief_title>Naproxen Sodium Extended-Release Actual Use Study</brief_title>
	<detailed_description>Issues on adverse event data are addressed in the Adverse Event section. The following acronyms and abbreviations were used in the results section. - General Educational Development (GED)</detailed_description>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Self report use of Over The Counter (OTC) analgesics Able to read and understand English Provide written informed consent (subjects 12 17 years of age provide written as sent and/ or parent or legal guardian provide written consent) Purchase the investigational product Have participated in a study involving OTC analgesics in the last 12 months They or someone else in the household work for a market research company, an advertising agency, a public relations firm, pharmaceutical company, as a healthcare professional, or as part of a health care practice Have a history of known allergies to nonsteroidal antiinflammatory drugs (NSAIDs) (i.e., Naproxen, Ibuprofen, etc) or Aspirin Have a history of heart surgery in the last 60 days or plans for heart surgery in the next 60 days (Female subjects) are pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Non-prescription</keyword>
</DOC>